Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Validation of a Nomogram Predicting Non-Sentinel Lymph Node Metastases among Patients with Breast Cancer after Primary Systemic Therapy - a transSENTINA Substudy.

Liedtke C, Görlich D, Bauerfeind I, Fehm T, Fleige B, Helms G, Lebeau A, Staebler A, Ataseven B, Denkert C, Gerber B, Heil J, Krug D, Kümmel S, Schwentner L, von Minckwitz G, Loibl S, Untch M, Kühn T.

Breast Care (Basel). 2018 Dec;13(6):440-446. doi: 10.1159/000489565. Epub 2018 Nov 6.

PMID:
30800039
2.

Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease.

Wagner P, Kommoss FKF, Kommoss S, Hartkopf AD, Pasternak I, Oberlechner E, Greif K, Wallwiener M, Neis F, Abele H, Krämer B, Reisenauer C, Staebler A, Wallwiener D, Brucker SY, Taran FA.

Gynecol Oncol. 2019 Apr;153(1):49-54. doi: 10.1016/j.ygyno.2018.12.026. Epub 2019 Jan 8.

PMID:
30635214
3.

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).

Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, Euscher E, Hecht JL, Horn LC, Ioffe O, Matias-Guiu X, McCluggage WG, Mikami Y, Ordi J, Parkash V, Quddus MR, Quick CM, Staebler A, Zaloudek C, Nucci M, Malpica A, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S93-S113. doi: 10.1097/PGP.0000000000000524.

4.

Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.

Malpica A, Euscher ED, Hecht JL, Ali-Fehmi R, Quick CM, Singh N, Horn LC, Alvarado-Cabrero I, Matias-Guiu X, Hirschowitz L, Duggan M, Ordi J, Parkash V, Mikami Y, Ruhul Quddus M, Zaino R, Staebler A, Zaloudek C, McCluggage WG, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S9-S24. doi: 10.1097/PGP.0000000000000552.

5.

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany.

Iftner T, Neis KJ, Castanon A, Landy R, Holz B, Woll-Herrmann A, Iftner A, Staebler A, Wallwiener D, Hann von Weyhern C, Neis F, Haedicke-Jarboui J, Martus P, Brucker S, Henes M, Sasieni P.

J Clin Microbiol. 2019 Jan 2;57(1). pii: e01177-18. doi: 10.1128/JCM.01177-18. Print 2019 Jan.

6.

Malignancy rates of B3-lesions in breast magnetic resonance imaging - do all lesions have to be excised?

Preibsch H, Wanner LK, Staebler A, Hahn M, Siegmann-Luz KC.

BMC Med Imaging. 2018 Sep 10;18(1):27. doi: 10.1186/s12880-018-0271-7.

7.

Accuracy of Breast Magnetic Resonance Imaging Compared to Mammography in the Preoperative Detection and Measurement of Pure Ductal Carcinoma In Situ: A Retrospective Analysis.

Preibsch H, Beckmann J, Pawlowski J, Kloth C, Hahn M, Staebler A, Wietek BM, Nikolaou K, Wiesinger B.

Acad Radiol. 2019 Jun;26(6):760-765. doi: 10.1016/j.acra.2018.07.013. Epub 2018 Aug 24.

PMID:
30149976
8.

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Jimenez-Linan M, Karlan BY, Gentry-Maharaj A, Menon U, Polo SH, Candido Dos Reis FJ, Doherty JA, Gayther SA, Sharma R, Larson MC, Harnett PR, Hatfield E, de Andrade JM, Nelson GS, Steed H, Schildkraut JM, Carney ME, Høgdall E, Whittemore AS, Widschwendter M, Kennedy CJ, Wang F, Wang Q, Wang C, Armasu SM, Daley F, Coulson P, Jones ME, Anglesio MS, Chow C, de Fazio A, García-Closas M, Brucker SY, Cybulski C, Harris HR, Hartkopf AD, Huzarski T, Jensen A, Lubiński J, Oszurek O, Benitez J, Mina F, Staebler A, Taran FA, Pasternak J, Talhouk A, Rossing MA, Hendley J; AOCS Group, Edwards RP, Fereday S, Modugno F, Ness RB, Sieh W, El-Bahrawy MA, Winham SJ, Lester J, Kjaer SK, Gronwald J, Sinn P, Fasching PA, Chang-Claude J, Moysich KB, Bowtell DD, Hernandez BY, Luk H, Behrens S, Shah M, Jung A, Ghatage P, Alsop J, Alsop K, García-Donas J, Thompson PJ, Swerdlow AJ, Karpinskyj C, Cazorla-Jiménez A, García MJ, Deen S, Wilkens LR, Palacios J, Berchuck A, Koziak JM, Brenton JD, Cook LS, Goode EL, Huntsman DG, Ramus SJ, Köbel M.

J Pathol Clin Res. 2018 Oct;4(4):250-261. doi: 10.1002/cjp2.109. Epub 2018 Sep 21.

9.

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile.

Kommoss FK, Karnezis AN, Kommoss F, Talhouk A, Taran FA, Staebler A, Gilks CB, Huntsman DG, Krämer B, Brucker SY, McAlpine JN, Kommoss S.

Br J Cancer. 2018 Aug;119(4):480-486. doi: 10.1038/s41416-018-0187-6. Epub 2018 Jul 27.

PMID:
30050154
10.

Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary.

Pilsworth JA, Cochrane DR, Xia Z, Aubert G, Färkkilä AEM, Horlings HM, Yanagida S, Yang W, Lim JLP, Wang YK, Bashashati A, Keul J, Wong A, Norris K, Brucker SY, Taran FA, Krämer B, Staebler A, van Meurs H, Oliva E, Shah SP, Kommoss S, Kommoss F, Gilks CB, Baird DM, Huntsman DG.

Mod Pathol. 2019 Apr;32(4):593. doi: 10.1038/s41379-018-0085-8.

PMID:
29968850
11.

Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor.

Loibl S, Weber K, Huober J, Krappmann K, Marmé F, Schem C, Engels K, Pfitzner BM, Kümmel S, Furlanetto J, Hartmann A, Darb-Esfahani S, Müller V, Staebler A, von Minckwitz G, Kronenwett R, Denkert C.

Clin Cancer Res. 2018 Jul 15;24(14):3358-3365. doi: 10.1158/1078-0432.CCR-17-2947. Epub 2018 Apr 4.

PMID:
29618617
12.

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Tołoczko A, Tiezzi DG, Taran FA, Sinn P, Sieh W, Sharma R, Rothstein JH, Ramón Y Cajal T, Paz-Ares L, Oszurek O, Orsulic S, Ness RB, Nelson G, Modugno F, Menkiszak J, McGuire V, McCauley BM, Mack M, Lubiński J, Longacre TA, Li Z, Lester J, Kennedy CJ, Kalli KR, Jung AY, Johnatty SE, Jimenez-Linan M, Jensen A, Intermaggio MP, Hung J, Herpel E, Hernandez BY, Hartkopf AD, Harnett PR, Ghatage P, García-Bueno JM, Gao B, Fereday S, Eilber U, Edwards RP, de Sousa CB, de Andrade JM, Chudecka-Głaz A, Chenevix-Trench G, Cazorla A, Brucker SY; Australian Ovarian Cancer Study Group, Alsop J, Whittemore AS, Steed H, Staebler A, Moysich KB, Menon U, Koziak JM, Kommoss S, Kjaer SK, Kelemen LE, Karlan BY, Huntsman DG, Høgdall E, Gronwald J, Goodman MT, Gilks B, García MJ, Fasching PA, de Fazio A, Deen S, Chang-Claude J, Candido Dos Reis FJ, Campbell IG, Brenton JD, Bowtell DD, Benítez J, Pharoah PDP, Köbel M, Ramus SJ, Goode EL.

Mayo Clin Proc. 2018 Mar;93(3):307-320. doi: 10.1016/j.mayocp.2017.10.023.

13.

TERT promoter mutation in adult granulosa cell tumor of the ovary.

Pilsworth JA, Cochrane DR, Xia Z, Aubert G, Färkkilä AEM, Horlings HM, Yanagida S, Yang W, Lim JLP, Wang YK, Bashashati A, Keul J, Wong A, Norris K, Brucker SY, Taran FA, Krämer B, Staebler A, van Meurs H, Oliva E, Shah SP, Kommoss S, Kommoss F, Gilks CB, Baird DM, Huntsman DG.

Mod Pathol. 2018 Jul;31(7):1107-1115. doi: 10.1038/s41379-018-0007-9. Epub 2018 Feb 15. Erratum in: Mod Pathol. 2018 Jul 3;:.

PMID:
29449679
14.

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.

Kommoss S, McConechy MK, Kommoss F, Leung S, Bunz A, Magrill J, Britton H, Kommoss F, Grevenkamp F, Karnezis A, Yang W, Lum A, Krämer B, Taran F, Staebler A, Lax S, Brucker SY, Huntsman DG, Gilks CB, McAlpine JN, Talhouk A.

Ann Oncol. 2018 May 1;29(5):1180-1188. doi: 10.1093/annonc/mdy058.

PMID:
29432521
15.

The immunopeptidomic landscape of ovarian carcinomas.

Schuster H, Peper JK, Bösmüller HC, Röhle K, Backert L, Bilich T, Ney B, Löffler MW, Kowalewski DJ, Trautwein N, Rabsteyn A, Engler T, Braun S, Haen SP, Walz JS, Schmid-Horch B, Brucker SY, Wallwiener D, Kohlbacher O, Fend F, Rammensee HG, Stevanović S, Staebler A, Wagner P.

Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951. doi: 10.1073/pnas.1707658114. Epub 2017 Nov 1.

16.

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Ovarian Tumor Tissue Analysis (OTTA) Consortium, Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Tołoczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf A, Ryan A, Chudecka-Głaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubiński J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Ursula E, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, Anna A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus SJ.

JAMA Oncol. 2017 Dec 1;3(12):e173290. doi: 10.1001/jamaoncol.2017.3290.

17.

[Erratum to: The 2016 update of the S3 guideline for malignant tumours of the ovary : Role of pathology in diagnosis, therapy and clinical management of epithelial tumours].

Staebler A, Mayr D.

Pathologe. 2017 Nov;38(6):545-546. doi: 10.1007/s00292-017-0372-z. German. No abstract available.

PMID:
29038912
18.

Preoperative breast MR Imaging in patients with primary breast cancer has the potential to decrease the rate of repeated surgeries.

Preibsch H, Blumenstock G, Oberlechner E, Brucker SY, Hahn M, Staebler A, Wiesinger B, Claussen CD, Nikolaou K, Siegmann-Luz KC.

Eur J Radiol. 2017 Sep;94:148-153. doi: 10.1016/j.ejrad.2017.06.020. Epub 2017 Jul 1.

PMID:
28712698
19.

Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.

Kommoss S, Hartkopf AD, Krämer B, Bunz AK, Grevenkamp F, Kommoss F, Pasternak J, Arbabi SM, Wallwiener M, Staebler A, Lax SF, Brucker SY, Taran FA.

J Cancer Res Clin Oncol. 2017 Nov;143(11):2183-2188. doi: 10.1007/s00432-017-2474-7. Epub 2017 Jul 14.

PMID:
28710714
20.
21.

Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder.

Warzecha HN, Fend F, Steinhilber J, Abele H, Henes M, Harland N, Staebler A.

Virchows Arch. 2017 Sep;471(3):347-353. doi: 10.1007/s00428-017-2165-4. Epub 2017 Jun 7.

PMID:
28589387
22.

Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.

Preibsch H, Richter V, Bahrs SD, Hattermann V, Wietek BM, Bier G, Kloth C, Blumenstock G, Hahn M, Staebler A, Nikolaou K, Wiesinger B.

Eur J Radiol. 2017 May;90:181-187. doi: 10.1016/j.ejrad.2017.02.045. Epub 2017 Mar 2.

PMID:
28583631
23.

Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate.

Sahbai S, Taran FA, Staebler A, Wallwiener D, la Fougère C, Brucker S, Dittmann H.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1511-1519. doi: 10.1007/s00259-017-3692-6. Epub 2017 Apr 3.

PMID:
28374119
24.

Decidualization is Impaired in Endometrial Stromal Cells from Uterine Rudiments in Mayer-Rokitansky-Küster-Hauser Syndrome.

Brucker SY, Eisenbeis S, König J, Lamy M, Salker MS, Zeng N, Seeger H, Henes M, Schöller D, Schönfisch B, Staebler A, Taran FA, Wallwiener D, Rall K.

Cell Physiol Biochem. 2017;41(3):1083-1097. doi: 10.1159/000464116. Epub 2017 Feb 27.

25.

Better resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review.

Kommoss S, Kommoss F, Diebold J, Lax S, Schmidt D, Staebler A, du Bois A, Pfisterer J.

Br J Cancer. 2017 Jan;116(3):287-292. doi: 10.1038/bjc.2016.416. Epub 2016 Dec 22.

26.

CD56 (Neural Cell Adhesion Molecule) Expression in Ovarian Carcinomas: Association With High-Grade and Advanced Stage But Not With Neuroendocrine Differentiation.

Bösmüller HC, Wagner P, Pham DL, Fischer AK, Greif K, Beschorner C, Sipos B, Fend F, Staebler A.

Int J Gynecol Cancer. 2017 Feb;27(2):239-245. doi: 10.1097/IGC.0000000000000888.

PMID:
27984374
27.

Second Opinion Expert Pathology in Endometrial Cancer: Potential Clinical Implications.

Grevenkamp F, Kommoss F, Kommoss F, Lax S, Fend F, Wallwiener D, Schönfisch B, Krämer B, Brucker SY, Taran FA, Staebler A, Kommoss S.

Int J Gynecol Cancer. 2017 Feb;27(2):289-296. doi: 10.1097/IGC.0000000000000870.

PMID:
27922981
28.

Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial.

Schwentner L, Helms G, Nekljudova V, Ataseven B, Bauerfeind I, Ditsch N, Fehm T, Fleige B, Hauschild M, Heil J, Kümmel S, Lebeau A, Schmatloch S, Schrenk P, Staebler A, Loibl S, Untch M, Von Minckwitz G, Liedtke C, Kühn T.

Breast. 2017 Feb;31:202-207. doi: 10.1016/j.breast.2016.11.012. Epub 2016 Nov 24.

PMID:
27889596
29.

Pericervical Injection of 99mTc-Nanocolloid Is Superior to Peritumoral Injection for Sentinel Lymph Node Detection of Endometrial Cancer in SPECT/CT.

Sahbai S, Taran FA, Fiz F, Staebler A, Becker S, Solomayer E, Wallwiener D, la Fougère C, Brucker S, Dittmann H.

Clin Nucl Med. 2016 Dec;41(12):927-932.

PMID:
27749429
30.

Prevalence and distribution pattern of nodal metastases in advanced ovarian cancer.

Bachmann C, Bachmann R, Kraemer B, Brucker SY, Staebler A, Fend F, Rothmund R, Wallwiener D.

Mol Clin Oncol. 2016 Oct;5(4):483-487. Epub 2016 Aug 5.

31.

L1CAM: amending the "low-risk" category in endometrial carcinoma.

Kommoss F, Kommoss F, Grevenkamp F, Bunz AK, Taran FA, Fend F, Brucker SY, Wallwiener D, Schönfisch B, Greif K, Lax S, Staebler A, Kommoss S.

J Cancer Res Clin Oncol. 2017 Feb;143(2):255-262. doi: 10.1007/s00432-016-2276-3. Epub 2016 Sep 30.

PMID:
27695947
32.

A bead-based western for high-throughput cellular signal transduction analyses.

Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, Joos TO, Kling S, Poetz O, Fehm T, Neubauer H, Kuster B, Templin MF.

Nat Commun. 2016 Sep 23;7:12852. doi: 10.1038/ncomms12852.

33.

HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy.

Peper JK, Bösmüller HC, Schuster H, Gückel B, Hörzer H, Roehle K, Schäfer R, Wagner P, Rammensee HG, Stevanović S, Fend F, Staebler A.

Oncoimmunology. 2015 Jul 1;5(5):e1065369. doi: 10.1080/2162402X.2015.1065369. eCollection 2016 May.

34.

Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study.

Schmitz J, Schwab J, Schwenck J, Chen Q, Quintanilla-Martinez L, Hahn M, Wietek B, Schwenzer N, Staebler A, Kohlhofer U, Aina OH, Hubbard NE, Reischl G, Borowsky AD, Brucker S, Nikolaou K, la Fougère C, Cardiff RD, Pichler BJ, Schmid AM.

Cancer Res. 2016 Sep 15;76(18):5512-22. doi: 10.1158/0008-5472.CAN-15-0642. Epub 2016 Jul 27.

35.

Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype.

McConechy MK, Färkkilä A, Horlings HM, Talhouk A, Unkila-Kallio L, van Meurs HS, Yang W, Rozenberg N, Andersson N, Zaby K, Bryk S, Bützow R, Halfwerk JB, Hooijer GK, van de Vijver MJ, Buist MR, Kenter GG, Brucker SY, Krämer B, Staebler A, Bleeker MC, Heikinheimo M, Kommoss S, Blake Gilks C, Anttonen M, Huntsman DG.

J Natl Cancer Inst. 2016 Jun 13;108(11). pii: djw134. doi: 10.1093/jnci/djw134. Print 2016 Nov. Erratum in: J Natl Cancer Inst. 2017 Apr 1;109(4):.

36.

Relationship Between Hematogenous Tumor Cell Dissemination and Cellular Immunity in DCIS Patients.

Gruber IV, Hartkopf AD, Hahn M, Taran FA, Staebler A, Wallwiener D, Brucker SY, Hanke J, Fehm T.

Anticancer Res. 2016 May;36(5):2345-51.

PMID:
27127142
37.

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer.

Bösmüller HC, Wagner P, Peper JK, Schuster H, Pham DL, Greif K, Beschorner C, Rammensee HG, Stevanović S, Fend F, Staebler A.

Int J Gynecol Cancer. 2016 May;26(4):671-9. doi: 10.1097/IGC.0000000000000672.

PMID:
26905331
38.

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.

Anglesio MS, Wang YK, Maassen M, Horlings HM, Bashashati A, Senz J, Mackenzie R, Grewal DS, Li-Chang H, Karnezis AN, Sheffield BS, McConechy MK, Kommoss F, Taran FA, Staebler A, Shah SP, Wallwiener D, Brucker S, Gilks CB, Kommoss S, Huntsman DG.

J Natl Cancer Inst. 2016 Feb 1;108(6):djv428. doi: 10.1093/jnci/djv428. Print 2016 Jun.

PMID:
26832771
39.

[Tumor of the mesosalpinx with unclear differentiation].

Nann D, Gahlen S, Keul HG, Voigt HJ, Fend F, Staebler A.

Pathologe. 2016 Feb;37(1):84-7. doi: 10.1007/s00292-015-0128-6. German.

PMID:
26794496
40.

Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response.

Preibsch H, Wanner L, Bahrs SD, Wietek BM, Siegmann-Luz KC, Oberlecher E, Hahn M, Staebler A, Nikolaou K, Wiesinger B.

Eur Radiol. 2016 Jun;26(6):1590-6. doi: 10.1007/s00330-015-4011-x. Epub 2015 Sep 17.

PMID:
26382845
41.

Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma.

Hoang LN, McConechy MK, Köbel M, Anglesio M, Senz J, Maassen M, Kommoss S, Meng B, Postovit L, Kelemen LE, Staebler A, Brucker S, Krämer B, McAlpine JN, Gilks CB, Huntsman DG, Lee CH.

Int J Gynecol Cancer. 2015 Sep;25(7):1187-93. doi: 10.1097/IGC.0000000000000492.

PMID:
26166557
42.

Role of Pelvic and Para-aortic Lymph Node Metastases in Optimally Cytoreduced Advanced Ovarian Cancer.

Bachmann C, Bachmann R, Brucker SY, Staebler A, Fend F, Grischke EM, Wallwiener D.

Anticancer Res. 2015 Jun;35(6):3479-84. Retraction in: Anticancer Res. 2015 Jul;35(7):4372.

PMID:
26026113
43.

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.

Iftner T, Becker S, Neis KJ, Castanon A, Iftner A, Holz B, Staebler A, Henes M, Rall K, Haedicke J, von Weyhern CH, Clad A, Brucker S, Sasieni P.

J Clin Microbiol. 2015 Aug;53(8):2509-16. doi: 10.1128/JCM.01013-15. Epub 2015 May 27.

44.

Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.

Pérez-Gómez E, Andradas C, Blasco-Benito S, Caffarel MM, García-Taboada E, Villa-Morales M, Moreno E, Hamann S, Martín-Villar E, Flores JM, Wenners A, Alkatout I, Klapper W, Röcken C, Bronsert P, Stickeler E, Staebler A, Bauer M, Arnold N, Soriano J, Pérez-Martínez M, Megías D, Moreno-Bueno G, Ortega-Gutiérrez S, Artola M, Vázquez-Villa H, Quintanilla M, Fernández-Piqueras J, Canela EI, McCormick PJ, Guzmán M, Sánchez C.

J Natl Cancer Inst. 2015 Apr 8;107(6):djv077. doi: 10.1093/jnci/djv077. Print 2015 Jun.

45.

The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.

Bachmann C, Brucker SY, Kraemer B, Rothmund R, Staebler A, Fend F, Wallwiener D, Grischke EM.

J Cancer Res Clin Oncol. 2015 Aug;141(8):1475-80. doi: 10.1007/s00432-015-1945-y. Epub 2015 Mar 5. Retraction in: Bachmann C, Brucker SY, Kraemer B, Rothmund R, Staebler A, Fend F, Wallwiener D, Grischke EM. J Cancer Res Clin Oncol. 2016 Feb;142(2):529.

PMID:
25739827
46.

The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer.

Bachmann R, Rothmund R, Krämer B, Brucker SY, Königsrainer A, Königsrainer I, Beckert S, Staebler A, NguyenHuu P, Grischke E, Wallwiener D, Bachmann C.

J Invest Surg. 2015 Jun;28(3):160-6. doi: 10.3109/08941939.2014.994794. Epub 2015 Jan 7.

PMID:
25565126
47.

CNS metastases in breast cancer patients: prognostic implications of tumor subtype.

Bachmann C, Schmidt S, Staebler A, Fehm T, Fend F, Schittenhelm J, Wallwiener D, Grischke E.

Med Oncol. 2015 Jan;32(1):400. doi: 10.1007/s12032-014-0400-2. Epub 2014 Nov 30.

PMID:
25433950
48.

Vacuum-assisted breast biopsy with 7-gauge, 8-gauge, 9-gauge, 10-gauge, and 11-gauge needles: how many specimens are necessary?

Preibsch H, Baur A, Wietek BM, Krämer B, Staebler A, Claussen CD, Siegmann-Luz KC.

Acta Radiol. 2015 Sep;56(9):1078-84. doi: 10.1177/0284185114549224. Epub 2014 Sep 17.

PMID:
25232187
49.

Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors.

Rothmund R, Hartkopf A, Joachim C, Walter CB, Wallwiener M, Kraemer B, Brucker SY, Staebler A, Taran FA.

Arch Gynecol Obstet. 2014 Dec;290(6):1195-200. doi: 10.1007/s00404-014-3320-7. Epub 2014 Jul 1.

PMID:
24981048
50.

[Mucinous ovarian neoplasms. Prognostically mostly excellent, infrequently a wolf in sheep's clothing].

Lax S, Staebler A.

Pathologe. 2014 Jul;35(4):327-35. doi: 10.1007/s00292-014-1912-4. Review. German.

PMID:
24962632

Supplemental Content

Loading ...
Support Center